Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?

Caroline Happold; Thierry Gorlia; L. Burt Nabors; Sara C. Erridge; David A. Reardon; Christine Hicking; Martin Picard; Roger Stupp; Michael Weller

doi:10.1007/s11060-018-2786-8

Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?

Caroline Happold, Thierry Gorlia, L. Burt Nabors, Sara C. Erridge, David A. Reardon, Christine Hicking, Martin Picard, Roger Stupp, Michael Weller

School of Population Health Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	163-171
Journal	Journal of Neuro-Oncology
Volume	138
Issue number	1
DOIs	https://doi.org/10.1007/s11060-018-2786-8
Publication status	Published - 1 May 2018

Access to Document

10.1007/s11060-018-2786-8

http://link.springer.com/10.1007/s11060-018-2786-8

Cite this

@article{e1972ce0053f41d28fc86786d6d8ed35,

title = "Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?",

author = "Caroline Happold and Thierry Gorlia and Nabors, \{L. Burt\} and Erridge, \{Sara C.\} and Reardon, \{David A.\} and Christine Hicking and Martin Picard and Roger Stupp and Michael Weller",

year = "2018",

month = may,

day = "1",

doi = "10.1007/s11060-018-2786-8",

language = "English",

volume = "138",

pages = "163--171",

journal = "Journal of Neuro-Oncology",

issn = "0167-594X",